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ABSTRACT 
 
Incontinentia pigmenti is a rare multisystem X-linked dominant genetic disorder caused 
by mutations in IKBKG, encoding inhibitor of kappa light polypeptide gene enhancer in 
B-cells. Almost 80% or all cases result from a recurrent intragenic deletion mutation that 
removes exon 4-10 deletion. At present, this mutation can be detected by a multi-
primer polymerase chain reaction (PCR) technique although current protocols may 
preferentially amplify the wild-type allele and may miss the deletion. Here, we report a 
female infant with incontinentia pigmenti that also affected her mother and sister, and 
two spontaneously aborted male siblings. We developed a modified PCR amplification 
method that provides more robust detection of the exon 4-10 deletion mutation, which 
was demonstrated in all affected females in this pedigree.  
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INTRODUCTION 
 
 Incontinentia pigmenti (IP; MIM308300), also known as Bloch-Sulzberger 
syndrome, is an X-linked dominant disorder, with variable dermatological, ocular, 
skeletal, dental and neurological manifestations.1 Rarely, cleft lip and palate can also 
occur.2 Affected males almost always die prenatally, but cells expressing the mutated X 
3 
 
chromosome are eliminated selectively around the time of birth, and thus females with 
IP usually survive and exhibit extremely skewed X-inactivation. Clinically, the prominent 
cutaneous signs of IP occur in four classic phases: perinatal inflammatory erythema, 
vesicles and pustules, followed by verrucous papules and hyperkeratosis, and then 
hyperpigmentation, and subsequently, skin pallor, dermal atrophy and scarring.3 
In 2000, the International Incontinentia Pigmenti Consortium demonstrated that 
IP results from mutations in NEMO, encoding NF-kappa-B essential modulator (NF-B), 
which later became known as inhibitor of nuclear factor kappa-B kinase subunit gamma 
(IKK-) with the gene referred to as IKBKG.4 The role of IKK- is to regulate NF-B 
activation of several genes involved in inflammation and cell survival, and thus in IP the 
lack of active NF-B makes cells more prone to apoptosis.4 The most common 
pathogenic mutation in IKBKG in patients with IP is a large intragenic deletion that 
removes exons 4-10, inclusive.5 This single mutation accounts for ~80% of the total 
molecular pathology of IP and thus accurate methods to detect it are vital for disease 
diagnostics. Technically, this is not straightforward as there is a non-functional copy of 
IKBKG running in the opposite direction,6 which may also show deletions with no 
phenotypic consequences, and thus new polymerase chain reaction (PCR) primer 
protocols have been developed,6 and then further modified,7 to address this potential 
concern. Although the newer protocols allow for both internal controls and false 
negatives,7 there remains some bias in PCR amplification for the wild-type over the 
deletion mutant allele, which we address in this report. We also present the clinical 
features and molecular pathology of IP in a Filipino family with 5 affected members. 
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CASE 
 
 The proband is a 24-day-old girl born at full term to unrelated parents. Full 
details of the pedigree are shown in Fig. 1a (the proband is individual III-5). Clinically, 
there were linear streaks of vesicles following Blaschko’s lines, on the trunk, back and 
extremities but which spared the face, palms and soles (Fig. 1b). Bilateral clefting 
abnormalities affecting the lip and extending to the nose and palate were noted. A 
patch of hair loss was also seen on the scalp vertex. The rest of the physical 
examinations were unremarkable. Her mother (now aged 31 years) and an older sister 
(now 4 years) had similar perinatal pathologies. Notably, they both presented with 
linear vesicles at birth, which then evolved into Blascho-linear verrucous plaques. These 
hyperkeratotic lesions were then replaced by hyperpigmented linear discoloration and 
currently the skin manifestations are residual hypopigmented linear patches devoid of 
skin appendages. She has one older healthy brother (now aged 5 years) but her mother 
also reported spontaneous abortions of two male fetuses between 24-28 weeks’ 
gestation. No abnormalities were reported in her father or other paternal or maternal 
relatives. 
Laboratory tests did not identify any haematological or biochemical 
abnormalities. Following informed consent, a skin biopsy of a vesicle sampled under 
local anaesthetic revealed eosinophilic spongiosis with scattered, single necrotic 
keratinocytes in the epidermis and a moderately dense eosinophilic infiltrate in the 
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superficial dermis, consistent with the vesicular stage of IP (Fig. 2a). To determine 
whether the pathogenic mutation in IKBKG was the most frequently observed large 
intragenic deletion, we developed a modified version of a published protocol,7 using the 
three primers detailed in that paper, but changing the buffer and amplification 
conditions because the existing protocol favours amplification of the wild-type allele 
because of large differences in the GC content of the PCR products: the 733-bp 
fragment (internal control) has a 56% GC content, whereas the 1045-bp deletion 
fragment has a 62% GC content. Presence of the deletion by PCR was demonstrated in 
the proband as well as the affected sister and mother (Fig. 2b) and was confirmed in the 
proband’s DNA using L2Rev to Sanger sequence the 1045-bp fragment (Fig. 2c). Full 
details of the new recommended PCR protocol are presented in Figure 2d. 
Most cases of IP are sporadic, with new mutations usually being paternal rather 
than maternal in origin.8 Familial IP occurs in up to 25% of cases, with reports of up to 
four generations manifesting IP.9 With regard to genotype-phenotype correlation, there 
is widespread clinical heterogeneity even within those individuals whose IP results from 
the recurrent IKBKG deletion, findings which reflect variable patterns and degrees of X-
inactivation. Indeed, only the proband in this study has central facial abnormalities. Of 
most phenotypic concern in IP are potential central nervous system abnormalities, 
which can include developmental delay, seizures, hemiplegia, hemiparesis, spasticity, 
microcephaly and cerebellar ataxia.10 None of these, however, manifested in any 
individuals in this Filipino family. 
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CONCLUSION 
 
 We report a neonate with vesicular stage IP, whose mother and sister have IP 
too; two affected male siblings also died in utero. Clinically, these familial cases highlight 
the progressive stages of IP as it evolves. Using a modified PCR method we 
demonstrated presence of the recurrent exon 4-10 deletion mutation in IKBKG in all 
three living individuals with IP. This improved protocol delivers robust detection of this 
mutant allele and can be recommended for use in other laboratories.  
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Figure legends 
 
Figure 1. Pedigree and clinical features in the proband. (a) The pedigree shows that the 
affected mother (II-9) has 5 offspring, four of whom have IP, including two male fetuses 
(III-2 and III-4) that were spontaneously aborted at 24 and 28 weeks gestation. (b) 
Blaschko-linear vesicles on the trunk and limbs in the proband (III-5) at 3 weeks of age. 
There is also cleft lip and palate and alopecia affecting the scalp vertex. 
 
Figure 2. Skin and molecular pathology. (a) Light microscopy of lesional skin reveals 
eosinophilic spongiosis, collections of eosinophils within the upper epidermis, vesicle 
formation and haemorrhage (haematoxylin and eosin; bar = 25 m); (b) PCR 
amplification of peripheral blood genomic DNA identifies the recurrent intragenic 
deletion in IKBKG (for these specific PCR conditions the upper 1045-bp band indicates 
presence of the deletion, whereas the 733-bp band is wild-type) in the proband (III-5), 
and affected sister (III-3) and affected mother (II-9) but not control (Co) (MW = 
molecular weight marker); (c) Sanger sequencing of the 1045-bp band from the 
proband’s amplified DNA confirms a breakpoint in intron 3/10 that deletes exon 4-10, 
inclusive; (d) details of the changes made to the PCR protocol for optimal detection of 
this internal deletion mutation. 
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